HLA-C and neoplasm: It has been reported that conserved tumor exon junctions between MC38 cells and B16-F10 cells can be presented on MHC class I.28Furthermore, prophylactic exposure to these conserved tumor exon junctions has been reported to confer protective effects against B16-F10 growth, attributed to elicited anti-tumor immune responses.28